Solid pseudopapillary tumor of the pancreas

Clinical profile and outcome of solid papillary neoplasm of the pancreas

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

TCTR

Registry ID

TCTR20220322011

Enrollment

Registered

2022-03-22

Start date

2022-03-22

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

solid pseudopapillary neoplasm solid pseudopapillary neoplasm, pancreas, surgery, outcome

Interventions

Patients who underwent surgical intervention for solid pseudopapillary neoplasm of the pancreas.

Treatment

Patients with solid pseudopapillary neoplasm of the pancreas.

Eligibility

Sex/Gender

All

Age

14 Years to 60 Years

Inclusion criteria

Inclusion criteria: patients whose histopathology report of the resected specimen confirmed Solid pseudopapillary neoplasm

Exclusion criteria

Exclusion criteria: Other pathological diagnoses like intraductal papillary mucinous neoplasm, cystadenoma, cystadenocarcinoma, neuroendocrine tumors, and pseudocyst

Design outcomes

Primary

Measure	Time frame
Perioperative Mortality 30 days Days	—

Secondary

Measure	Time frame
Perioperative Morbidity 30 days Days,Longterm complication 3 years Recurrence	—

Countries

India

Contacts

Public ContactSukanta Ray

Institute of Postgraduate Medical Educat

drsukantaray@yahoo.co.in8095960200

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026